COMBINATION OF ERBB-2 TARGETING AGENT AND A BISPECIFIC ANTIBODY THAT COMPRISES AN ANTIGEN-BINDING SITE THAT CAN BIND AN EPITOPE ON AN EXTRACELLULAR PART OF ERB-2 AND AN ANTIGEN-BINDING SITE THAT CAN BIND AN EPITOPE ON EXTRACELLULAR PART OF ERBB-3, FOR USE IN A METHOD OF TREATMENT OF AN INDIVIDUAL THAT HAS ERBB-2, ERBB-2/ERBB-3 POSITIVE TUMOUR
Publication
EP3600412A1
Kind: A1
Mar 25, 2026
Applicants
Merus B.V.
Inventors
THROSBY, Mark, GEUIJEN, Cecilia Anna Wilhelmina, MAUSSANG-DETAILLE, David Andre Baptiste, LOGTENBERG, Ton
IPC Classifications
A61K 39/395 20060101AFI20181005BHEP
C07K 16/28 20060101ALI20181005BHEP
C07K 16/32 20060101ALI20181005BHEP
C07K 16/46 20060101ALI20181005BHEP
C07K 16/30 20060101ALI20181005BHEP
Designated States
AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR